查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565048

全球神經設備市場

Neurology Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球神經設備市場預計將達到 187 億美元

2023年全球神經設備市場預計為126億美元，預計2030年將達到187億美元，2023-2030年分析期間複合年成長率為5.9%。腦脊髓液管理設備是本報告分析的細分市場之一，預計複合年成長率為 5.7%，到分析期結束時將達到 71 億美元。在分析期間，神經刺激設備細分市場的複合年成長率預計為 6.7%。

美國市場預期成長33億美元，中國複合年成長率為9.9%

預計 2023 年美國神經設備市場規模將達 33 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到44億美元，2023-2030年分析期間複合年成長率為9.9%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.3% 和 6.0%。在歐洲，德國的複合年成長率預計為 2.9%。

全球神經設備市場—主要趨勢與促進因素總結

神經設備如何推進神經系統疾病的治療？

神經設備對於診斷、監測和治療從癲癇和帕金森氏症到中風和創傷性腦損傷等各種神經系統疾病至關重要。這些設備涵蓋廣泛的技術，包括神經刺激設備、神經診斷系統和腦脊髓液管理設備。由於人口老化和對精神疾病認知的提高，神經系統疾病呈上升趨勢，對這些設備的需求呈指數級成長。用於治療運動障礙的深部腦部刺激 (DBS) 等創新技術和腦電圖 (EEG) 等先進影像技術使診斷和治療方法更加準確、侵入性更小，幫助患者的治療效果顯著改善。

科技在塑造神經設備創新方面發揮什麼作用？

神經設備的進步與機器人、人工智慧 (AI) 和小型化等領域的技術創新密切相關。人工智慧驅動的診斷工具正在提高早期發現神經系統疾病的能力，機器人輔助手術正在提高神經外科手術的精確度和安全性。此外，穿戴式神經刺激設備可提供低頻電脈衝來治療偏頭痛和憂鬱症疾病，為藥物治療提供了一種非侵入性治療方法。小型化促進了較小的植入式設備的開發，使 DBS 等治療方法對患者來說更加舒適和容易接受。這些進步不僅擴大了神經設備的功能，也改善了神經系統疾病患者的生活品質。

人口和醫療保健趨勢如何影響神經科設備市場？

推動神經系統設備需求的一個主要因素是神經系統疾病的盛行率不斷增加，特別是在人口老化中。阿茲海默症、中風和帕金森氏症等疾病變得越來越常見，需要先進的設備進行診斷和長期管理。此外，不斷成長的醫療保健支出和對提高神經護理品質的日益關注正在刺激對新技術和治療方法的投資。隨著醫療基礎設施的改善和對神經系統疾病的意識提高，新興市場對神經系統設備的需求也迅速增加。同時，監管機構正在簡化具有顯著治療效果的神經設備的核准流程，進一步推動市場成長。

神經設備市場的成長受到多種因素的推動

神經系統設備市場的成長受到多種因素的推動，包括神經系統疾病盛行率的上升，特別是在人口老化中，導致對先進診斷和治療設備的需求增加。人工智慧診斷、機器人輔助手術和穿戴式神經刺激設備等技術進步正在提高這些治療的準確性和有效性。此外，不斷成長的醫療保健支出，尤其是在新興市場，使這些先進設備更容易獲得。此外，非侵入性治療選擇和改善患者治療結果的趨勢正促使醫療保健提供者採用更新、更複雜的神經設備。對創新神經設備日益成長的監管支持也進一步提振了市場。

受訪企業範例（共42家）

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Penumbra, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP15943

Global Neurology Devices Market to Reach US$18.7 Billion by 2030

The global market for Neurology Devices estimated at US$12.6 Billion in the year 2023, is expected to reach US$18.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Cerebrospinal Fluid Management Devices, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$7.1 Billion by the end of the analysis period. Growth in the Neurostimulation Devices segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 9.9% CAGR

The Neurology Devices market in the U.S. is estimated at US$3.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Neurology Devices Market - Key Trends & Drivers Summarized

How Are Neurology Devices Advancing the Treatment of Neurological Disorders?

Neurology devices have become integral in diagnosing, monitoring, and treating a wide range of neurological disorders, from epilepsy and Parkinson's disease to stroke and traumatic brain injury. These devices encompass a broad range of technologies, including neurostimulation devices, neurodiagnostic systems, and cerebrospinal fluid management equipment. With neurological disorders on the rise due to aging populations and increasing awareness of mental health conditions, the demand for these devices has grown exponentially. Innovations such as deep brain stimulation (DBS) for treating movement disorders, as well as advanced imaging technologies like electroencephalograms (EEGs), are enabling more precise and less invasive diagnosis and treatment options, significantly improving patient outcomes.

What Role Does Technology Play in Shaping Neurology Device Innovations?

The advancement of neurology devices is closely tied to technological innovations in fields like robotics, artificial intelligence (AI), and miniaturization. AI-powered diagnostic tools are enhancing the ability to detect neurological disorders early, while robotic-assisted surgery is increasing the precision and safety of neurosurgical procedures. Additionally, wearable neurostimulation devices, which deliver low-frequency electrical pulses to treat conditions like migraines or depression, are providing non-invasive alternatives to medication. Miniaturization has enabled the development of smaller, implantable devices, making treatments like DBS more comfortable and accessible for patients. These advancements are not only expanding the capabilities of neurology devices but also improving the quality of life for individuals with neurological conditions.

How Are Demographic and Healthcare Trends Impacting the Neurology Devices Market?

The growing prevalence of neurological disorders, particularly among aging populations, is a key factor driving demand for neurology devices. Conditions such as Alzheimer’s disease, stroke, and Parkinson’s are becoming more common, requiring advanced devices for both diagnosis and long-term management. In addition, increased healthcare spending and a rising focus on improving the quality of neurological care are spurring investments in new technologies and therapies. Emerging markets are also seeing a surge in demand for neurology devices as healthcare infrastructure improves, and awareness of neurological disorders rises. Meanwhile, regulatory bodies are streamlining approval processes for neurology devices that demonstrate significant therapeutic benefits, further driving market growth.

The Growth in the Neurology Devices Market Is Driven by Several Factors

The growth in the neurology devices market is driven by several factors, including the rising incidence of neurological disorders, particularly in aging populations, which is creating greater demand for advanced diagnostic and therapeutic devices. Technological advancements, such as AI-driven diagnostics, robotic-assisted surgeries, and wearable neurostimulation devices, are enhancing the precision and effectiveness of these treatments. Additionally, increasing healthcare expenditure, particularly in emerging markets, is making these advanced devices more accessible. Moreover, the trend toward non-invasive treatment options and improved patient outcomes is prompting healthcare providers to adopt newer, more sophisticated neurology devices. The expanding regulatory support for innovative neurology devices is further fueling the market, as faster approvals are encouraging the adoption of cutting-edge technologies.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Penumbra, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Neurology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Neurological Disorders Driving Device Demand
    • Technological Advancements in Neurostimulation Devices and Implants
    • Increasing Use of Wearable Neurology Devices for Continuous Monitoring
    • Growing Adoption of AI and Machine Learning in Neurological Diagnostics
    • Expansion of Minimally Invasive Surgery in Neurosurgery Devices
    • Advances in Brain-Computer Interface (BCI) Technology
    • Increasing Use of Telemedicine in Neurology and Remote Monitoring Devices
    • Development of Portable Imaging Systems for Point-of-Care Diagnostics
    • Growth in Geriatric Population Leading to Higher Incidence of Neuro Disorders
    • Rising Research Investments in Neuroscience and Brain Mapping Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cerebrospinal Fluid Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cerebrospinal Fluid Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Neurostimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neurology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neurology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neurology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neurology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neurology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Neurology Devices by Device Type - Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Neurology Devices by Device Type - Percentage Breakdown of Value Sales for Cerebrospinal Fluid Management, Neurostimulation, Interventional Neurology, Neurosurgery and Other Device Types for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Neurology Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Neurology Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION